Shopping Cart
- Remove All
- Your shopping cart is currently empty
ML 145 is a selective and potent antagonist of human GPR35, with no significant activity against GPR35 in any of its immediate rodent homologs.ML 145 has potential anti-inflammatory activity for the study of immunoinflammation.ML 145 is a novel non-steroidal anti-inflammatory agent for the study of rheumatoid arthritis.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
2 mg | $92 | In Stock | |
5 mg | $148 | In Stock | |
10 mg | $218 | In Stock | |
25 mg | $369 | In Stock | |
50 mg | $549 | In Stock | |
100 mg | $789 | In Stock | |
200 mg | $1,132 | In Stock |
Description | ML 145 is a selective and potent antagonist of human GPR35, with no significant activity against GPR35 in any of its immediate rodent homologs.ML 145 has potential anti-inflammatory activity for the study of immunoinflammation.ML 145 is a novel non-steroidal anti-inflammatory agent for the study of rheumatoid arthritis. |
Targets&IC50 | CXCR8:20.1 nM, GPR35:21.7 μM |
In vitro | ML 145 is a selective and competitive human antagonist of GPR35/CXCR8 with an IC50/EC50 value of 20.1 nM, compared to GPR35, which is over 1000-fold more selective than GPR55, which has an IC50/EC50 value of 21.7 μM. [1] In addition, ML 145 at 10 μM completely blocked the internalization of human FLAG-GPR35-eYFP in response to various concentrations of Zaprinast, Cromolyn disodium and Pamoate. In rodents, ML 145 was ineffective in mice and showed only a slight non-competitive inhibitory effect in rats. [2] |
Alias | ML145 |
Molecular Weight | 482.57 |
Formula | C24H22N2O5S2 |
Cas No. | 1164500-72-4 |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
Solubility Information | DMSO: 40 mg/mL (82.89 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.